Lanzhou Foci Pharmaceutical Co (SZSE:002644) Change In Receivables : ¥0.0 Mil (TTM As of Sep. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Lanzhou Foci Pharmaceutical Co Change In Receivables?

Lanzhou Foci Pharmaceutical Co's change in receivables for the quarter that ended in Sep. 2024 was ¥0.0 Mil. It means Lanzhou Foci Pharmaceutical Co's Accounts Receivable stayed the same from Jun. 2024 to Sep. 2024 .

Lanzhou Foci Pharmaceutical Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥59.5 Mil. It means Lanzhou Foci Pharmaceutical Co's Accounts Receivable declined by ¥59.5 Mil from Dec. 2022 to Dec. 2023 .

Lanzhou Foci Pharmaceutical Co's Accounts Receivable for the quarter that ended in Sep. 2024 was ¥344.0 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Lanzhou Foci Pharmaceutical Co's Days Sales Outstanding for the three months ended in Sep. 2024 was 149.71.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Lanzhou Foci Pharmaceutical Co's liquidation value for the three months ended in Sep. 2024 was ¥134.7 Mil.

Lanzhou Foci Pharmaceutical Co Change In Receivables Historical Data

The historical data trend for Lanzhou Foci Pharmaceutical Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lanzhou Foci Pharmaceutical Co Change In Receivables Chart

Lanzhou Foci Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-84.70

-48.90

-66.85

-189.54

59.50

Lanzhou Foci Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Lanzhou Foci Pharmaceutical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

Lanzhou Foci Pharmaceutical Co (SZSE:002644) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Lanzhou Foci Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	343.973	/	209.651	*	91
=	149.71

2. In Ben Graham's calculation of liquidation value, Lanzhou Foci Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Lanzhou Foci Pharmaceutical Co's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	351.622	-	677.622	+	0.75 * 343.973	+	0.5 * 405.499
=	134.7

Lanzhou Foci Pharmaceutical Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Lanzhou Foci Pharmaceutical Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Lanzhou Foci Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lanzhou Foci Pharmaceutical Co Ltd (SZSE:002644) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

68 Foci Street ChangGuan Region, Lanzhou, CHN, 730046

Website

http://www.fczy.com

Lanzhou Foci Pharmaceutical Co Ltd is a pharmaceutical company based in China. The company is engaged in the production and sales of Chinese traditional medicine. In addition to manufacturing, the company also conducts research to develop new herbal drugs. Its product portfolio consists of concentrated pills, granules, hard capsules, concentrated decoctions and medicinal wine. The products of the company are exported to more than 27 countries including the United States, Canada, Japan, Australian, Russia, Ukraine, among others.

Executives

Sun Yu	Directors, executives
Su Wen Bo	Supervisors
An Wen Ting	Securities Affairs Representative

Lanzhou Foci Pharmaceutical Co Headlines

No Headlines